BDR Pharmaceuticals
  • Home
    • About BDR
    • CMD Profile
    • News
    • Blogs
    • Our Strengths
    • Facilities
    • Press Release
    • Company Policies
    • CSR Sustainability
    • Mission & Vision
    • Ethical Marketing Division
    • Milestones
    • Global Presence
    • Board of Directors
    About Us
  • Products
    • Innovation & Technology
    • Regulatory
    • Research & Development
    • IPR
    • Quality Policy
    • Contract Manufacturing
    Expertise
    • Culture
    • Job Openings
    Careers
  • Investors
  • Contact
  1. Home
  2. Press Release

Press Release

Innovative Breakthroughs in Pharmaceuticals: Press Releases and Updates

news Chronicle Pharmabiz
Authored Article Jul 02, 2024

How Indian Generic Medicines are reshaping the global Pharma Industry

Read More
news Times Of India
Authored Article Jul 01, 2024

Prostate cancer: Unawareness, accessibility, and affordability sink the ship of men with prostate cancer

Read More
news Firstpost
Authored Article Jul 01, 2024

Lung and breast cancer: Bridging gap for newer therapies to deliver better clinical outcomes

Read More
news Biospectrum
Interview Jul 01, 2024

We are focusing on cancer and critical care in a big way

Read More
news YourStory
Industry Story Jul 01, 2024

Access to expertise has democratised itself beyond boundaries- 20 quotes from India's COVID-19 struggle

Read More
news YourStory
Exclusive Story Jul 01, 2024

Remdesivir maker BDR Pharma eyes IPO, India MSME Summit is back, and other top SMB stories of the week

Read More
news Biospectrum
Exclusive Story Jul 01, 2024

BDR Pharma partners with Varenyam Healthcare to revolutionise Anaesthesia practices in India

Read More
news Express Pharma
Exclusive Story Jul 01, 2024

BDR Pharma partners with Varenyam Healthcare to launch Sugmadex in India

Read More
news PharmaBiz
Exclusive Story Jul 01, 2024

BDR Pharma partners with Varenyam Healthcare to launch anaesthetic drug Sugmadex

Read More
news ET Healthworld
Exclusive Story Jul 01, 2024

BDR Pharma, Varenyam launch Sugammadex anaesthesia drugs in India

Read More
news VC Circle
Exclusive Story Jul 01, 2024

BDR Pharmaceuticals funding multiples private equity covid-19 remdesivir

Read More
news YourStory
Exclusive Story Jul 01, 2024

Remdesivir manufacturer BDR Pharma raises Rs 685 Cr at a valuation of $95M

Read More
news MoneyControl
Exclusive Story Jul 01, 2024

Multiples PE-led consortium to buy 9.3% in BDR Pharma for Rs 685 crore

Read More
news ET Healthworld
Exclusive Story Jul 01, 2024

BDR Pharma raises Rs 685 crore from multiples, other investors

Read More
news Financial Express
Exclusive Story Jul 01, 2024

BDR Pharmaceuticals launches anti-cancer drug for advanced gastric cancer

Read More
  • ‹
  • 1
  • 2
  • 3
  • 4
  • ›

Print Media Coverage

Saamana

BDR introduced prostate cancer medicine at one-third the cost

Express Pharma

By 2023, pharma industry is expected to be worth more than $1 trillion

Gujarat Samachar

Training by 52 doctorate teachers experienced in applied sciences (Student Placement )

The Hindu

How is India Streamlining the pharma sector? (Editions) - National Story Published in 7+ Editions

MoneyControl

Cancer treatment : What is stem cell therapy, and how does it work ?

Express Pharma

Supply chain transformation in healthcare and pharma

The Healthsite

Understanding The Role Of Generic Medicines In Accessible Cancer Treatment

BioSpectrum

BDR Pharma launches world’s first Enzalutamide oral solution for prostate cancer treatment

Express Pharma

BDR Pharma launches BDENZA oral solution for prostate cancer

MoneyControl

Prostate cancer in men: Early detection through symptoms, diagnosis

BW Healthcare

BDR Pharmaceuticals Unveils BDENZA: Oral Solution For Prostate Cancer Treatment

Press Trust Of India

BDR Pharmaceuticals introduces prostate ‘cancer treatment drug in oral solution form

Business Standard

BDR Pharmaceuticals launches prostate cancer drug in oral solution form

FE Healthcare

BDR Pharma launches oral solution for prostate cancer in India

Economic Times

BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution form

  • ‹
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • ›
Discover Previous
News Section
awards-cta
Discover Next
Ethical Marketing
certification-cta
footer-logo

BDR is a “niche” player in both global and domestic arena

Company
About BDR Milestones Our Mission & Vision Our Achivements CMD Profile
Expertise
Innovation & Technology Regulatory Research & Development IPR Quality Policy Contract Manufacturing
Quick Links
Home Products News Careers Contact
Registered Office

BDR Pharmaceuticals Internationals Pvt. Ltd. Registered Office, 407/408, Sharda Chambers, New Marine Lines, Mumbai 400020, India.

+91-22-40560560
Corporate Office

Grievance officer: Mr. Pawan Srivastava

Ombudsman, 6, Engineering Centre, 9 Mathew Road, Opera House, Mumbai- 400004, India.

+91-22-40560560
ombudsman@bdrpharma.com

Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at the buyer's risk. Products currently covered by valid patents in India are offered for R&D purpose in accordance with Section 107(A) of the Patents Act, 1970.

© BDR Pharmaceuticals International Pvt. Ltd, All Rights Reserved. Designed By Ideamagix.

Terms & Conditions | Privacy Policy

  • Home
  • About Us
    • Overview
    • Our Strengths
    • Achievements
    • CSR Sustainability
    • Milestones
    • CMD Profile
    • Facilities
    • Mission & Vision
    • Global Presence
    • News
    • Press Release
    • Ethical Marketing Division
    • Board Of Directors
    • Blogs
    • Company Policies
  • Products
  • Expertise
    • Innovation & Technology
    • Regulatory
    • Research & Development
    • IPR
    • Quality Policy
    • Contract Manufacturing
  • Careers
    • Culture
    • Job Openings
  • Investors
  • Contact